UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Multinational drugmakers hypocritical in cancer, orphan drug biz’
Multinational drugmakers are demanding Seoul’s quicker approval for insuran...
by Nam Doo-hyun
|
2018-05-23 15:06
라인
Obesity treatment Saxenda supplied to 10 general hospitals
Novo Nordisk Pharma Korea said it has expanded the sales of Saxenda (ingred...
by Nam Doo-hyun
|
2018-05-23 11:13
라인
Refusals of off-label drugs spiked last year
Government regulators’ refusals of off-label drugs surged last year. Off-la...
by Nam Doo-hyun
|
2018-05-17 15:23
라인
How China’s scrapping of tariffs will affect Korea’s drug exports?
Korean drug exporters are paying attention to how China’s exemption of impo...
by Nam Doo-hyun
|
2018-05-16 12:14
라인
Merck’s Erbitux extends RSA status
Merck Korea and the health authorities have renewed their risk-sharing agre...
by Nam Doo-hyun
|
2018-05-15 14:31
라인
Biotech shares weaken on KONEX, too
As biotech stocks on KOSPI and KOSDAQ have turned downward since mid-April,...
by Nam Doo-hyun
|
2018-05-15 14:02
라인
‘Breast cancer drug Faslodex needs insurance coverage’
AstraZeneca Korea’s breast cancer treatment Faslodex (ingredient: fulvestra...
by Nam Doo-hyun
|
2018-05-11 11:31
라인
Samsung BioLogics shares recover despite window dressing controversy
Biotech and pharmaceutical shares are bouncing back from recent massive sli...
by Nam Doo-hyun
|
2018-05-10 11:08
라인
Va-Q-Tec to up investment in Korean biopharmaceuticals
Germany’s logistics and packaging company Va-Q-Tec said it would significan...
by Nam Doo-hyun
|
2018-05-09 11:54
라인
Pharma, biotech shares tank amid Samsung BioLogics debacle
Pharmaceutical and biotech shares are suffering a massive blow from repercu...
by Nam Doo-hyun
|
2018-05-08 11:20
라인
How much cheaper will Keytruda be as first-line treatment?
The pharmaceutical industry is paying attention to how much the price of MS...
by Nam Doo-hyun
|
2018-05-03 14:51
라인
Will US oncology conference boost Korean biotech shares?
Whether the upcoming annual meeting of the American Society of Clinical Onc...
by Nam Doo-hyun
|
2018-04-27 16:29
라인
Guerbet Korea under fire for exploiting monopoly drug
Guerbet Korea, the supplier of contrast media Lipiodol, is being criticized...
by Nam Doo-hyun
|
2018-04-26 15:37
라인
GC Pharma has most patents among large drug suppliers
GC Pharma had the largest number of patents among top-ranking local drugmak...
by Nam Doo-hyun
|
2018-04-26 11:08
라인
Pharma shares on the rise since early this year
Pharmaceutical and biotech shares have recently suffered declines, but most...
by Nam Doo-hyun
|
2018-04-25 13:56
라인
3 Korean pipelines listed in 537 new drug candidates in US
Three Korean treatments were included in 537 innovative drug candidates for...
by Nam Doo-hyun
|
2018-04-24 11:21
라인
Insulin Toujeo beats Tresiba in patient number
Novo Nordisk Korea recently boasted that its insulin product Tresiba (ingre...
by Nam Doo-hyun
|
2018-04-23 16:01
라인
Korean units of GSK, Pfizer send highest dividends to parent firms
Korean units of GlaxoSmithKline (GSK) and Pfizer showed the highest propens...
by Nam Doo-hyun
|
2018-04-20 14:48
라인
Biotech stocks could be overpriced: analysts
Analysts are warning investors that biotech shares could be overpriced, as ...
by Nam Doo-hyun
|
2018-04-19 13:34
라인
AstraZeneca up, Novartis down in Q1 outpatient prescriptions
AstraZeneca Korea’s outpatient prescription drug sales expanded by 7 billio...
by Nam Doo-hyun
|
2018-04-18 14:58
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top